<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6034DB1B-CE27-4AA4-AA2A-F7543FB0588F"><gtr:id>6034DB1B-CE27-4AA4-AA2A-F7543FB0588F</gtr:id><gtr:name>Children's Cancer and Leukaemia Group (CCLG)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C14348DA-D359-4201-BF1C-98CA22511F70"><gtr:id>C14348DA-D359-4201-BF1C-98CA22511F70</gtr:id><gtr:name>Nanjing University</gtr:name><gtr:address><gtr:line1>The President's office</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>China</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/134469FE-2E04-475C-88C9-B43CFFFF0D7D"><gtr:id>134469FE-2E04-475C-88C9-B43CFFFF0D7D</gtr:id><gtr:name>European Society of Paediatric Oncology (SIOPE)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BF6E9D7C-AF75-47D4-8EE8-CACFD251EB6C"><gtr:id>BF6E9D7C-AF75-47D4-8EE8-CACFD251EB6C</gtr:id><gtr:name>Waters Corporation / Micromass U K Ltd</gtr:name><gtr:address><gtr:line1>Floats Road</gtr:line1><gtr:line2>Wythenshawe</gtr:line2><gtr:line4>Manchester</gtr:line4><gtr:postCode>M23 9LZ</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BE15F3A1-6818-4832-BA9E-2E101288FB61"><gtr:id>BE15F3A1-6818-4832-BA9E-2E101288FB61</gtr:id><gtr:name>Micro Art</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Neuroscience</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6034DB1B-CE27-4AA4-AA2A-F7543FB0588F"><gtr:id>6034DB1B-CE27-4AA4-AA2A-F7543FB0588F</gtr:id><gtr:name>Children's Cancer and Leukaemia Group (CCLG)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C14348DA-D359-4201-BF1C-98CA22511F70"><gtr:id>C14348DA-D359-4201-BF1C-98CA22511F70</gtr:id><gtr:name>Nanjing University</gtr:name><gtr:address><gtr:line1>The President's office</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>China</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/134469FE-2E04-475C-88C9-B43CFFFF0D7D"><gtr:id>134469FE-2E04-475C-88C9-B43CFFFF0D7D</gtr:id><gtr:name>European Society of Paediatric Oncology (SIOPE)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BF6E9D7C-AF75-47D4-8EE8-CACFD251EB6C"><gtr:id>BF6E9D7C-AF75-47D4-8EE8-CACFD251EB6C</gtr:id><gtr:name>Waters Corporation / Micromass U K Ltd</gtr:name><gtr:address><gtr:line1>Floats Road</gtr:line1><gtr:line2>Wythenshawe</gtr:line2><gtr:line4>Manchester</gtr:line4><gtr:postCode>M23 9LZ</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BE15F3A1-6818-4832-BA9E-2E101288FB61"><gtr:id>BE15F3A1-6818-4832-BA9E-2E101288FB61</gtr:id><gtr:name>Micro Art</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7B37377E-AAF0-4C32-BA3D-0395632DCBB7"><gtr:id>7B37377E-AAF0-4C32-BA3D-0395632DCBB7</gtr:id><gtr:firstName>Julian</gtr:firstName><gtr:otherNames>Leether</gtr:otherNames><gtr:surname>Griffin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/907E1B92-1938-40D7-A859-21C839BD2C4B"><gtr:id>907E1B92-1938-40D7-A859-21C839BD2C4B</gtr:id><gtr:firstName>Carole</gtr:firstName><gtr:otherNames>Lesley</gtr:otherNames><gtr:surname>Cummins</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2E41BEBB-8E6F-4F56-84CD-2609120B17E8"><gtr:id>2E41BEBB-8E6F-4F56-84CD-2609120B17E8</gtr:id><gtr:firstName>Yrjo</gtr:firstName><gtr:surname>Hiltunen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3DB9FD8B-786B-4376-AB3C-17A65713E358"><gtr:id>3DB9FD8B-786B-4376-AB3C-17A65713E358</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>C</gtr:otherNames><gtr:surname>Peet</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1A5A6541-3FF1-4504-8C35-3BD4E8D8F722"><gtr:id>1A5A6541-3FF1-4504-8C35-3BD4E8D8F722</gtr:id><gtr:firstName>Olli</gtr:firstName><gtr:otherNames>H</gtr:otherNames><gtr:surname>Grohn</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/08095B91-2881-42A3-8277-D416E3BE160F"><gtr:id>08095B91-2881-42A3-8277-D416E3BE160F</gtr:id><gtr:firstName>Risto</gtr:firstName><gtr:surname>kauppinen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D9BD8753-7741-4EA8-A1BD-AEB5FD526D49"><gtr:id>D9BD8753-7741-4EA8-A1BD-AEB5FD526D49</gtr:id><gtr:firstName>Theodoros</gtr:firstName><gtr:surname>Arvanitis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9116ABCA-FFB2-44E7-B579-588913C779B5"><gtr:id>9116ABCA-FFB2-44E7-B579-588913C779B5</gtr:id><gtr:firstName>Jussi-Pekka</gtr:firstName><gtr:surname>Usenius</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601327"><gtr:id>2DA98D4A-A19E-46B1-A8C9-325C03DA41E1</gtr:id><gtr:title>Lipids Detected by 1H Magnetic Resonance Spectroscopy as Brain Tumour Biomarkers</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601327</gtr:grantReference><gtr:abstractText>We use Proton Magnetic Resonance Spectroscopy (MRS) to examine the biochemical nature of lipid species in paediatric brain tumours. Brain tumours are the most common form of solid tumours in the child population. Clinical management of paediatric brain tumour patients would benefit from imaging techniques able to indicate tumour aggressiveness in regard to growth and invasion as well as allowing assessment of treatment response.

Our goal is to find a link between the MRS lipids and clinical behaviour of brain cancer. Preclinical and clinical studies have indicated that saturated lipids by MRS are indicative of the degree of malignancy. Similarly, during successful therapy MRS signals from unsaturated lipids change indicating cell death at an early stage. 

The work will be carried out in one of the largest children?s cancer centers in the UK. The MRS results recorded from tumours will be compared with those obtained from tumour tissue collected at operations. Clinical information, including patient outcome and event-free survival, will be compared with MRS lipids and other lipid analyses from tumours. 

We expect that the results from the MRS project will allow doctors to predict how aggressive a brain tumour is and how well it will respond to treatment without a biopsy. Repeating MRS during treatment it is expected should provide an efficient means for monitoring treatment response, making it possible to adjust treatment to achieve an optimal outcome without delay.</gtr:abstractText><gtr:technicalSummary>1H magnetic resonance spectroscopy (MRS) reveals resonances from CH2/CH3 groups of saturated mobile lipids in brain tumours, but not in the healthy brain parenchyma. Evidence from the applicants and others links the 1H MRS detectable lipids to poor prognosis. Our data from experimental gliomas show that 1H MRS signals from polyunsaturated lipids (PUFA) are excellent non-invasive biomarkers for apoptosis induced by cytotoxic therapy. The proposal is to qualify biomarker value of 1H MRS detected saturated and PUFA lipids. Hypotheses, claiming that (a) saturated 1H MRS lipids are prognostic biomarkers and (b) PUFAs biomarkers for therapy monitoring, will be examined. The project involves both retrospective (80 patients) and prospective (~35 patients annually) paediatric brain tumour cohorts of Birmingham Children Hospital (BCH) as clinical patient population. Paediatic patients undergo regular 1H MRS during the follow-up at BCH, extending to six years for a subset of cases, and tissue specimens are obtained from about 80% of tumours. State-of-the-art in vivo MRS technology, data processing and lipid analyses, including MALDI-MS technique on histological specimens, will be used. The project involves two commercial partners (Waters, MA, USA and MRSTools Inc., Finland). The 1H MRS non-invasive biomarkers are expected to improve patient management, reduce need for invasive diagnostic procedures and enable efficient objective therapy monitoring. In long term, specific molecular biomarkers may be linked to targeted new therapeutic agents.</gtr:technicalSummary><gtr:fund><gtr:end>2011-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>437642</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Micro Art</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>MicroArt</gtr:description><gtr:id>18C4EEED-FD6F-4217-B102-2D43D8A53CCE</gtr:id><gtr:impact>There have been 2 journal paper publications which have featured MicroArt members. There have been moves towards CE marking of products. Health Agents is listed as a collaborator on the ENCCA FP7 NOE.</gtr:impact><gtr:outcomeId>AF93CA7540B-1</gtr:outcomeId><gtr:partnerContribution>MicroArt is a spin off company from the University Autonomia de Barcelona. They have expertise in software engineering and in particular the databases and clinical decision support systems. They provide an SME which can help commercialise products.</gtr:partnerContribution><gtr:piContribution>We have supplied clinical, imaging and laboratory data as well as clinical expertise and knowledge.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Society of Paediatric Oncology (SIOPE)</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>SIOPE- Brain Imaging Group</gtr:description><gtr:id>E679B96D-8AED-4B02-8227-D73F5E6704C8</gtr:id><gtr:impact>We have developed an international multi-modal MR imaging protocol for inlcusion in clinical trials.</gtr:impact><gtr:outcomeId>XpiyqYP8srr-1</gtr:outcomeId><gtr:partnerContribution>We have established a Brain Imaging Group as part of SIOP Europe and Dr Peet Co-Chairs this group. It has a dual function of radiological review for clinical trials and imaging research. Since SIOPE is the main body for designing and running clinical trials in children with cancer, the groups forms an ideal vehicle for translating advances in imaging research into clinical trials as a prelude to their inclusion in rountine clinical practice.</gtr:partnerContribution><gtr:piContribution>Dr Peet is the co-chair of the group and leads the imaging research activities.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Children's Cancer and Leukaemia Group (CCLG)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CCLG Functional Imaging Group</gtr:description><gtr:id>A7EFEBCE-9956-40B8-BE00-E2940450CF98</gtr:id><gtr:impact>17349783, 17823793, 18613254, 18835152, Multicentre projects have been presented at the International Society of Magnetic Resonance in Medicine, British Society of Neuroradiology and Interational Symposium of Pediatric Neuro-oncology. The CCLG has been awarded a &amp;pound;2.3Million programme grant from Cancer Research UK, EPSRC,MRC and DOH (England) which in part resulted from the input from this MRC biomarkers project.</gtr:impact><gtr:outcomeId>557DE47500F-1</gtr:outcomeId><gtr:partnerContribution>The CCLG provides a network of centres with clinical and clinical trials expertise in childhood cancer, it is the UKs network of these centres. The CCLG therefore provides the ideal partner for the translation of discoveries from single centre projects to a multicentre clinical environment. The CCLG has a functional imaging group which has clincians and scientists with expertise in this field further enhancing the translation of discoveries in this field to the multicentre network. Dr Peet is the chair of this group.</gtr:partnerContribution><gtr:piContribution>The CCLG's functional imaging group develops and evaluates functional imaging for the diagnosis, mangement and understanding of childhood cancer. It does this by translating innovations and pilot data from single centres of excellence to a multicentre clinical setting. We have provided the CCLG with pilot data and techniques which have allowed this translation. Mulitcentre studies have been presented at international conferences and are nearing readiness for journal publication.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nanjing University (NJU)</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Yu Sun, Nanjing, China</gtr:description><gtr:id>2A95B98F-0CD4-4E29-8626-3FB8F89C6F23</gtr:id><gtr:impact>We have recently had a paper accepted for publication which included both groups.
We have applied for a travel and collaboration fellowship to the Royal Society with a final outcome expected in April 2017, the award has already been granted by China.</gtr:impact><gtr:outcomeId>58c57306c2a1b6.09295781-1</gtr:outcomeId><gtr:partnerContribution>Yu Sun's group brings expertise in computer engineering and in image and signal processing to the collaboration. The large patient base in Nanjing also brings extra translationa potential to the collaboration.</gtr:partnerContribution><gtr:piContribution>Dr Yu Sun was a post doctoral research fellow in my group working on an EU project (STREP HealthAgents). Her background was in computer engineering with expertise in image and signal processing. After the fellowship, she returned to her home city of Nanjing in China and set up a group similar to mine at North Western University, collaborating closely with clinical colleagues in the adult and children's hospitals there. She how has a post where she spends time in China and time in Birmingham and we are setting up a close collaboration with an intend that team members spend time in both centres. We bring expertise in translating imaging research into advanced in clinical practice..</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Waters Corporation</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Waters Corporation, MALDI-MS</gtr:description><gtr:id>F8F36248-D6AE-45FC-BA7B-76B2F1D0451D</gtr:id><gtr:impact>Samples have been collected, stored and prepared and are awaiting analysis. A preliminary set of results were presented at the 2009 Keystone meeting on lipid metabolism.</gtr:impact><gtr:outcomeId>EBA3FE1AE89-1</gtr:outcomeId><gtr:partnerContribution>Dr Shockor has been advising on the use of MALDI-Mass Spectrometry for sample analysis and has secured equipment time.</gtr:partnerContribution><gtr:piContribution>We supply samples from childhood brain tumours, animals and cell lines as well as relevant clinical and biological information.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Society of Paediatric Oncology (SIOPE)</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>SIOP Europe</gtr:description><gtr:id>425D6563-E3FD-47D9-B17E-CBB4FF65CD58</gtr:id><gtr:impact>A grant application has been awarded for an EU FP7 Network of Excellence (&amp;pound;12 Million). A Peet leads the task on Functional Imaging.</gtr:impact><gtr:outcomeId>BBE10166941-1</gtr:outcomeId><gtr:partnerContribution>SIOPE (the international society for paediatric oncology) is a Europe wide consortium of centres for clinical trials in children with cancer. A recent grant application (12 million euros) has been submitted for an EU network of excellence which includes a workpackage on functional imaging led by Dr A Peet. The network provides a comprehensive set of clinical centres for the dissemination of our findings across Europe.</gtr:partnerContribution><gtr:piContribution>We provide expertise in functional imaging, including protocols for data collection, transfer and storage as well as analysis together with pilot data.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Electronics and Computer Science Southampton</gtr:department><gtr:description>Health Agents Consortium</gtr:description><gtr:id>5FE6E3BC-5057-4271-88DE-E84C65E953D9</gtr:id><gtr:impact>Four journal publications (no PMIDs since they are Engineering Journals), the decision support system has undergone preparation for CE marking.</gtr:impact><gtr:outcomeId>0A43DD5C38A-2</gtr:outcomeId><gtr:partnerContribution>The Health Agents Consortium was formed for an EU Framework 6 STREP to design and build a distributed database and data warehouse for MRS data for brain tumour diagnosis and prognosis. It enabled clinical decision support based on our MRS discoveries to be made available to a larger number of clinical centres.</gtr:partnerContribution><gtr:piContribution>We supplied MRS data on childhood brain tumours, helped to design and build the decision support system and in particular a graphical user interface for clinicians and tested the interface on clinicians.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>CCLG CNS Division Newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5BFE7300-E686-41E1-B569-B6722F0AC826</gtr:id><gtr:impact>The Central Nervous System Division of the CCLG produces quarterly newsletters for clinicians concerning its acitivities. Dr Peet wrote an article on functional imaging for the newsletter.

Dissemination of research to clinicians and encouragement to take part.</gtr:impact><gtr:outcomeId>26A32CF4984</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Articles for Contact Magazine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F819CAD4-0BD3-4F34-A70C-271FE76D447A</gtr:id><gtr:impact>Dr A Peet wrote an article on New Horizons in Imaging in Children's Cancer, March Issue 2009 and then an Article on The role of imaging in diagnosing childhood tumours in August 2015

Dissemination of information to the general public and patient groups as well as encouraging these groups to put forward their views concerning the research and ideas for future research</gtr:impact><gtr:outcomeId>A8F73589388</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2009,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference presentation - European Society for Magnetic Resonance in Medicine and Biology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8F36CB05-3483-4FF2-8AFB-833952519BF3</gtr:id><gtr:impact>Oral presentation on MRS lipids in brain tumours and an e-poster in the ESMRMB conference

Dissemination of outputs to clinicians in the field</gtr:impact><gtr:outcomeId>FC90EE47096</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited conference presentations - European Cancer Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6A0CEC4A-FE6B-4DE5-8674-A065D056E67A</gtr:id><gtr:impact>Two invited presentations were given by Dr A Peet - 1) response assessment in new drug trials 2) Assessing changes in tumour metabolism using magnetic resonance spectroscopy. A Peet also chaired the session on paediatric functional imaging. This is the main clinical cancer conference in Europe.

2009 Berlin, Germany - 2 invited key note oral presentations Apart from dissemination of information, the conference in 2009 was used to strengthen collaborations and led to the submission of an application for a Network of Excellence to EU FP7 (&amp;pound;12 Million).
2011 Stockholm, Europe - 1 invited key note oral presentation and 2 oral presentations of abstracts</gtr:impact><gtr:outcomeId>64D0033A1E7</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Ideas Lab and Maverick TV</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EF68DF6F-32D5-445D-9921-3A042680A5E2</gtr:id><gtr:impact>Dr Peet worked with Ideas Lab at the University of Birmingham who engaged with TV production teams notably Maverick TV who specialise in medical and scientific documentries. A video interview was filmed.

The research was highlighted to TV production teams and may lead a television documentary.</gtr:impact><gtr:outcomeId>A1D623876F9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference Presentation - European Society of Paediatric Radiology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>85792E62-77D5-408F-A9EA-E1FA4FCB8D12</gtr:id><gtr:impact>Oral Presentation on MRS of pineal tumours

Dissemination of information to paediatric radiologits</gtr:impact><gtr:outcomeId>234EC7682E1</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference Presentations - British Society of Neuroradiology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3951534E-CB25-479E-AD01-EB17085950B1</gtr:id><gtr:impact>2009 Nottingham - Two oral presentations on MRS in childhood brain tumours - one on glycine as a prognostic biomarker and another on mulit-centre data.
2014 Belfast - one oral presentation showing added value in diagnostic accuracy for an MRS based clinical decision support system compared with conventional radiological review for childrens brain tumours.

Dissemination to a key group of clinicians</gtr:impact><gtr:outcomeId>4AA0C897624</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview The Naked Scientists</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3A0EC0D2-0037-4D41-BB0B-19969106054C</gtr:id><gtr:impact>The interview was broadcast on BBC Cambridge radio station and a podcast on their website

Broad dissemination to a technically minded public audience.</gtr:impact><gtr:outcomeId>JajFf1HimXn</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference Presentation - National Cancer Research Institute</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>850E39D1-2249-4C9A-A14E-9CD4283EAE83</gtr:id><gtr:impact>2009 Birmingham Poster Presentation by group member on glycine as a prgnostic biomarker, shortlisted for the McElwain Prize.
2010 Liverpool Poster
2011 Liverpool Poster
2014 Liverpool poster

Dissemination to clinicians treating patients with cancer.</gtr:impact><gtr:outcomeId>9EEE6A4808D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press Release - BBC</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>65F4999F-5D96-4FA7-A671-9FD425E51F9E</gtr:id><gtr:impact>Dr Peet took part in a press release for BBC television involving a family with a child having a brain tumour who had raised funds for the group's research.

Made the general public aware of the research which is being undertaken.</gtr:impact><gtr:outcomeId>BD99036AC7B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference Presentations - International Society of Magnetic Resonance in Medicine</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>83377093-E9C9-452F-BAA2-3E1F159A7F07</gtr:id><gtr:impact>2009 Hawaii, USA - Oral presentation, 2 oral presentations and 8 posters
2010 Stockholm,Sweden - 2 posters
2011 Montreal, Canada -2 oral presentations, 4 posters
2013 Salt Lake City - 1 oral presentation, 6 posters
2014 Milan, Italy - 2 oral presentations, 6 posters

Dissemination of knowledge to clinicians and researchers in the field - neuroradiologists, MRI researchers</gtr:impact><gtr:outcomeId>BF31489B090</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007,2009,2010,2011,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference Presentation - International Symposium on Pediatric Neuro-Oncology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>E57F7697-00B5-498D-99F3-113E7DBDC96F</gtr:id><gtr:impact>Poster presentations based on our latest findings on spectroscopy of the smo mouse model (PMID 20842126) and our study on lipids as a biomarker of survival (manuscript in preparation).

Dissemination of knowledge to clinicians in the field.</gtr:impact><gtr:outcomeId>J3gMBm3ogob</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference Presentation - International Symposium for Pediatric Neuro-Oncology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BDD9A991-64AF-4667-98EC-23311BC449C6</gtr:id><gtr:impact>2008 - Chicago, USA - Three oral presentations given on Magnetic Resonance Spectroscopy and Magic Angle Spinning NMR of childhood brain tumours as diagnostic and prognostic aids.
2010 Vienna, Austria - 1 oral and 8 poster presentations
2012 Toronto, Canada - 5 poster presentations
2014 Singapore - 4 poster presentations

This is the main clinical pediatric neuro-oncology conference internationally. It occurs every other year. Dissemination to an audience of key clinicians - oncologists, surgeons, radiologists, radiotherapists and allied health professionals.</gtr:impact><gtr:outcomeId>5B0A12B9EC4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008,2010,2012,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article - Optimistic</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E98E3E85-BE23-42E2-832F-E7D4491314A6</gtr:id><gtr:impact>Dr Peet wrote an invited article for a book &amp;quot;what are you optiistic about&amp;quot; written by scientists for the lay audience on 2non-invasive techniques for diagnosing and managing brain tumours2.

The book is yet to be published but will give access to a broad range of the general public for dissemination of our work.</gtr:impact><gtr:outcomeId>E5C425CE6C9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2nd Metabolomics Sardinian Scientific School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>38D455D9-F3B3-446A-89DD-FAA722CB72AF</gtr:id><gtr:impact>2nd Metabolomics Sardinian Scientific School was aimed at post-grad students new to the field of metabolomics. We gave seminars and workshops in various tools and techniques in metabolomics.</gtr:impact><gtr:outcomeId>58be91ffd0e376.17281807</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited plenary presentation at ECCO/ESMO Stockholm</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>C34498D5-85A1-42EA-98CC-5B24CFED3687</gtr:id><gtr:impact>Around 200 delegates attended the presentation

Invitation to write a review article in Nature Reviews Clinical Oncology from the editor who was in the audience.</gtr:impact><gtr:outcomeId>C6ShLXBDg6B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>51884</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Childhood Eye Cancer Trust - Project Grant - Identification of molecular tools to guide treatment decisions in retinoblastoma</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>Childhood Eye Cancer Trust (CHECT)</gtr:fundingOrg><gtr:id>BDD91D6A-3A13-4F75-919E-52E9B47C54D9</gtr:id><gtr:outcomeId>619497B60490</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Leukaemia Research Project Grant</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>B760A208-9C42-4962-903C-A9FB9059301C</gtr:id><gtr:outcomeId>2B4E40A5B780</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>13000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ENCCA European Network for Cancer Research in Children and Adolescents (12m euros across 33 participants)</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>113EC854-FFF7-435E-9DDD-00DFCF65B516</gtr:id><gtr:outcomeId>PfeWaX58Rgq0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>68276</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BCH RF - PhD Studentship- Novel metabolite biomarkers of prognosis in childhood tumours</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>BCH Charities</gtr:fundingOrg><gtr:fundingRef>BCHRF287</gtr:fundingRef><gtr:id>F8BDF001-D9FD-4526-91DE-762F49C98E22</gtr:id><gtr:outcomeId>Q8TFf2MKYHa0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>64082</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BCH RF- Project Grant - Probing the tissue microenvironment of tumours by Magnetic Resonance Imaging</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>BCH Charities</gtr:fundingOrg><gtr:id>E9924B70-33D1-4DC7-9F43-F92F13FD2B69</gtr:id><gtr:outcomeId>d9ZE82iraPj0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Cancer Imaging Programme</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C7809/A10342</gtr:fundingRef><gtr:id>3F1CF048-61CE-4597-A02F-EF62383F63C1</gtr:id><gtr:outcomeId>1E570D88BB50</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Capital Awards Scheme - 3T MR Research Centre</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>CAB36BC7-621A-4A90-B5AC-0A7BACBAED27</gtr:id><gtr:outcomeId>01DACBE7E840</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>47000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Imagine for Margo Project Grant</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Imagine For Margo</gtr:fundingOrg><gtr:id>3FEEFF55-B712-4DE0-8234-FD17EE1E4D66</gtr:id><gtr:outcomeId>58c5c6267c7942.22121250</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>69737</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BCH RF - Project Grant - 31P Magnetic Resonance Spectroscopy as an early biomarker of tumour response in childhood tumours.</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>BCH Charities</gtr:fundingOrg><gtr:id>724D2A18-E771-4975-A0EA-CAB71934EA6D</gtr:id><gtr:outcomeId>kF5UQgAodRN0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BCH RF - Springboard Fellowship -Metabolomic approach to clinical evaluation of patients with known and suspected childhood neurodegenerative disorders</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>BCH Charities</gtr:fundingOrg><gtr:id>0B758776-F074-4F51-AB95-6B6F78867166</gtr:id><gtr:outcomeId>7F10546503F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BCH RF - Project Grant -Non-invasive investigation of brain metabolism and function in children with neurodegenerative diseases.</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>BCH Charities</gtr:fundingOrg><gtr:id>D16F8228-5201-4F7D-A5F3-5383E4CEB64E</gtr:id><gtr:outcomeId>0D68CC0A5020</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>342000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Technology Platform Diagnostic Imaging</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>42262123-B0D6-4B6A-93CE-0A905DF94CC5</gtr:id><gtr:outcomeId>3B54524017E0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>496000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Equipment Grant - HWB-NMR a National Resource for biomolecular research,</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>E78714FF-C9AC-4299-B55C-86E425450780</gtr:id><gtr:outcomeId>E11260AADBE0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>114553</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Healthcare Scientist Research Fellowship</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>5A936F8B-666F-47F8-BC48-E8D89D342828</gtr:id><gtr:outcomeId>N9v5aEHNxCW0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BCH RF - Project Grant - Molecular Characterization of Retinoblastoma</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>BCH Charities</gtr:fundingOrg><gtr:id>4DFB590B-F51E-4890-BE9D-E136BCF70709</gtr:id><gtr:outcomeId>5028D9558760</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2710000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Doctoral Training Centre (Life Sciences Interface) shared with E Claridge</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>42BA7382-3289-4A38-BA83-5F4659530518</gtr:id><gtr:outcomeId>YVbox1D9UQ30</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Leader Article for Archives of Diseases in Childhood</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>7282E441-4C3C-4CB8-962E-0AC7C40E30F6</gtr:id><gtr:outcomeId>CDCB917ACDB</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type><gtr:url>http://europepmc.org/abstract/MED/18463122</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>CCLG Radiology Guidelines</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:guidelineTitle>Radiology Guidelines</gtr:guidelineTitle><gtr:id>80D3C0ED-30BB-4553-BB4F-99B0A24AA0F7</gtr:id><gtr:impact>Standardisation of radiology protocols and a systematic strategy for evaluating new techniques and including them within the clinical practice is essential for translation of the new technology into routine clinicial practice.</gtr:impact><gtr:outcomeId>16EC77D9255</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Clinical decision support systems for magnetic resonance spectroscopy in brain tumous</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>4A933B06-FA3A-454B-A649-48E489FA1F93</gtr:id><gtr:outcomeId>1147F9C1DAF</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>CCLG CNS Division and Clinical Studies Group</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>61092DEF-5717-4745-ABE3-4D78933B4C5D</gtr:id><gtr:impact>Dr Peet is a member of the Central Nervous System Tumour Division of the CCLG and now the NCRI Clinical Studies subgroup. One role of this group is the construction of national protocols for radiology use in clinical trials. Dr Peet contributed to and is named on the UK guidelines for High Grade Glioma management, he was responsible for the functional imaging section.</gtr:impact><gtr:outcomeId>F372043F6EA</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Magnetic Resonance Spectroscopy named as being being important Safe and Sustainable neurosurgery for children</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>552AF3E4-2A0E-451A-8ABC-BECB122B516A</gtr:id><gtr:outcomeId>L5qgZHSPHCd</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in Lancet Neurology</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E1118127-F7F9-4DB1-9E98-90B761007B5E</gtr:id><gtr:outcomeId>B1E45F8DB92</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type><gtr:url>http://europepmc.org/abstract/MED/18031705</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SIOPE Brain Imaging Group Co-Chair</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>F5706E1A-E8C9-44BC-B00E-830714B790B1</gtr:id><gtr:impact>Formation of imaging guidelines across Europe for children with brain tumours, clinical trials led by SIOPE have improved survival, decreased morbidity and improved quality of life</gtr:impact><gtr:outcomeId>qrNN56s721g</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>MRS protocol for data collection, methodology for analysing the data and provision of a non-invasive diagnostic aid based on the data. The decision support system was developed at a single centre, tested in a multi-national study and has now been shown to give added accuracy compared with the standard method of radiological reporting.</gtr:description><gtr:id>97E26904-B2FB-4FE6-8FC0-7F726ED6A570</gtr:id><gtr:impact>Non-invasive diagnostic aid for children with brain tumours. This has been developed on retrospective single centre data and tested prospectively on a multi-centre basis as well as demonstrating added accuracy to conventional methods.</gtr:impact><gtr:outcomeId>67990316436</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>MRS profiles for non-invasive diagnosis of childhood brain tumours</gtr:title><gtr:type>Diagnostic Tool - Imaging</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>MRS lipids at presentation as a biomarker of survival in children with brain tumours. Initial single centre retrospective analysis (in 2007) provided the hypothesis for this biomarker study. We have been collecting single centre data prospectively to test the validity of the biomarker and this has been published in 2013. Other metabolites of prognostic value have been identified and published. Multi-centre is also being collected in readiness to test the biomarker more robustly.</gtr:description><gtr:id>62269F8E-FCAA-48C5-8133-4DCEDDB1D522</gtr:id><gtr:impact>Ability to identify agressive tumours which may not appear so on conventional histopathology or which are not biopsied.</gtr:impact><gtr:outcomeId>2EFA7D64D0B</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>MRS Lipds and metabolites as biomarkers of prognosis in childhood brain tumours</gtr:title><gtr:type>Diagnostic Tool - Imaging</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>A method based on metabolic profiles determined by Magic Angle Spinning high resolution NMR of intact tumour tissue for rapid diagnosis of childhood brain tumours. The method needs on 5mg of tissue and is non-destructive allowing the tissue to be used for other purposes eg validation afterwards. The technique and method for automated analysis has been developed. The technique is being developed via an NIHR grant.</gtr:description><gtr:id>76018F58-8293-47DA-81E0-77544758D76D</gtr:id><gtr:impact>The technique has been publised PMID19208232 and is undergoing further development and testing in a clinical arena.</gtr:impact><gtr:outcomeId>E7BA3AAEA4C</gtr:outcomeId><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Magic Angle Spinning NMR for rapid diagnosis on childhood brain tumour tissue</gtr:title><gtr:type>Diagnostic Tool - Imaging</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A web accessible database containing clinical information has been extended to include functional imaging data. This database forms the basis for the functional imaging group of the CCLG. Computer programs have been written to perform automated analysis and storage of SVS data. Classification can now be performed for a given case on the database at the request of a user. The most recent version of the database can be accessed at any computer.</gtr:description><gtr:id>68B18C28-EE2C-4065-A240-DD4042FCB463</gtr:id><gtr:impact>The development of the database has been essential for the dissemination work through the specific publications (pubmed number) 17506115, 18613254, 19067434, 19431141 and 19795380. DOI10.1016/j.ejca.2012.09.002</gtr:impact><gtr:outcomeId>9849A18488B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Development of database and online classification</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have previously developed diagnostic aids for children's brain tumours based on pattern recognition of magnetic resonance spectroscopy metabolite profiles. These of limited accuracy when the library of tumour cases has groups with greatly varying numbers in them which is commonly the case. The borderline synthetic minority oversampling method overcomes this problem by synthesising extra cases to make the groups have similar numbers in them. We have shown that this improves the diagnostic accuracy for rare tumours.</gtr:description><gtr:id>D3163152-E4B7-4752-B0B6-D95B86375CEB</gtr:id><gtr:impact>Rare tumours can be diagnosed more accurately using magnetic resonance spectroscopy.</gtr:impact><gtr:outcomeId>58c59d2163e247.25296977</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>bSMOTE for improved diagnostic accuracy using MRS when classes are unbalanced</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Assessing quality of MRS data is essential for its reliable use but poses many challenges. MRS quality is usually assessed by signal to noise ratio, spectral resolution and the fits spectral features. Small variations in simulated individual metabolites show instabilities in the fitting not revealed by the conventional parameters when the data quality is poor.</gtr:description><gtr:id>DAE2520D-7A9C-4703-9A62-E987A0175EBC</gtr:id><gtr:impact>Improved automated quality control of MRS data. The method has been published in NMR in Biomedicine.</gtr:impact><gtr:outcomeId>AFB2CBF2D30</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Assessment of MRS quality using small variations in basis functions</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Spectroscopy can provide highly reproducible quantitative information on variety of molecules, however manual analysis can be labour intensive and user dependant. An analysis tool has been developed which can be applied to both 1H HR-MAS and in-vivo 1H MRS facilitating the quantitative spectroscopic analysis of a mouse brain tumour model. A manuscript detailing the algorithm has been published PMID 20878762.</gtr:description><gtr:id>8B40679E-6767-4B91-BE85-D284E2AEF4E3</gtr:id><gtr:impact>Metabolite simulation functionality has been used in PMID 20331867 and the full fitting routine was required for data analysis presented in PMID 20842126. The software is also used routinely for the analysis of adult brain tumour and rodent tumour models in the Kauppinen research group. The software has been downloaded more than 700 times from 46 different countries since Feb 2010. The software is being prepared for commercialisation by a local SME of which a previous PhD student is a director.</gtr:impact><gtr:outcomeId>120544CEA50</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>TARQUIN fitting tool and metabolite simulation functionality</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.tarquin.sourceforge.net</gtr:url><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>A software analysis tool for analysing in vivo magnetic resonance spectroscopy data, which is being developed into a commercial product by an SME through funding stream at the University of Birmingham. CE marking is planned for 2015</gtr:description><gtr:id>7DCB3F4F-5870-42D8-B1E4-23B6F7A1EEF6</gtr:id><gtr:impact>Impacts will be established after dissemination</gtr:impact><gtr:outcomeId>5464b912857529.78226708</gtr:outcomeId><gtr:title>TARQUIN</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.tarquin.sourcefourge.net</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>AD9162D7-0A29-4FAF-AA2C-6A9130FD1A72</gtr:id><gtr:title>Glycine as a potential non-invasive prognostic biomarker in childhood brain tumours</gtr:title><gtr:parentPublicationTitle>Neuro-oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5dd35d052ea8c65fd6918a9c2cf5451"><gtr:id>b5dd35d052ea8c65fd6918a9c2cf5451</gtr:id><gtr:otherNames>Davies NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>58c7d8a1d2c210.83890743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED8CC414-4B8F-4529-90F0-D22B8D79E1B6</gtr:id><gtr:title>The size of cytoplasmic lipid droplets is a critical factor to the visibility of NMR lipid signal</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa6b6c24080c1135d3653d8e343c7a89"><gtr:id>fa6b6c24080c1135d3653d8e343c7a89</gtr:id><gtr:otherNames>Pan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>58c91f3adbd814.00547674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D21E4F7-AB4E-4697-9772-C455D43DCFB1</gtr:id><gtr:title>Detecting regions of active tumour using magnetic resonance spectroscopic imaging</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b34c39203e4c80ccb9fa77c6eb2c2fa"><gtr:id>9b34c39203e4c80ccb9fa77c6eb2c2fa</gtr:id><gtr:otherNames>Wilson MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>58c7c4dd58e9e4.63265208</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4644C097-92C8-4648-87C0-DBB5A0E1B635</gtr:id><gtr:title>Pattern recognition of single voxel 1H MRS metabolite profiles for classification and characterisation of childhood brain tumours according to type and grade</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5dd35d052ea8c65fd6918a9c2cf5451"><gtr:id>b5dd35d052ea8c65fd6918a9c2cf5451</gtr:id><gtr:otherNames>Davies NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>58c812ea323020.30972168</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1566943E-95A1-4564-A394-94FBD03CA7E6</gtr:id><gtr:title>Non-invasive diagnosis of relapse in childhood brain tumours using the invariance of metabolite profiles at presentation and relapse</gtr:title><gtr:parentPublicationTitle>Neuro-oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b00f3ee137a5c0d9dd2bc213da7d2e4"><gtr:id>6b00f3ee137a5c0d9dd2bc213da7d2e4</gtr:id><gtr:otherNames>Crosby H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>58c7d5f5a94519.48590226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBA55E6E-0462-4EF8-9D0D-A46EC4D525B8</gtr:id><gtr:title>Investigation of Paediatric Primitive Neuroectodermal Tumours Using Proton Nuclear Magnetic Resonance Spectroscopy</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84203276c78a03ce15de33fcaf2e7e81"><gtr:id>84203276c78a03ce15de33fcaf2e7e81</gtr:id><gtr:otherNames>Wilson, M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>58c16be94f6ba5.27359250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28D44CDD-9068-4200-A481-6278B1517E28</gtr:id><gtr:title>The value of MRS detectable lipids as prognostic markers in paediatric brain tumours (oral)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b34c39203e4c80ccb9fa77c6eb2c2fa"><gtr:id>9b34c39203e4c80ccb9fa77c6eb2c2fa</gtr:id><gtr:otherNames>Wilson MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>58c9495e52d8f9.65059625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0F7C950-DDFF-4FC8-A972-84B2271ADE8A</gtr:id><gtr:title>Short echo time single voxel 1H magnetic resonance spectroscopy in the diagnosis and characterisation of pineal tumours in children.</gtr:title><gtr:parentPublicationTitle>Pediatric blood &amp; cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/619596e9b5957aa1ef65c12d2517f14d"><gtr:id>619596e9b5957aa1ef65c12d2517f14d</gtr:id><gtr:otherNames>Harris LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1545-5009</gtr:issn><gtr:outcomeId>MvCqiEibJk7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00BA0E2B-E33F-403E-8A89-C0C6CBEF0635</gtr:id><gtr:title>HealthAgents: distributed multi-agent brain tumor diagnosis and&amp;nbsp;prognosis</gtr:title><gtr:parentPublicationTitle>Applied Intelligence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c06205c9af4e66c486e22cd8d138669"><gtr:id>4c06205c9af4e66c486e22cd8d138669</gtr:id><gtr:otherNames>Gonz?lez-V?lez H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>162758BAA98</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>565BD2AF-BC63-4C7F-AF33-4AC45A146BAA</gtr:id><gtr:title>The analysis of lipid and macromolecule signals in HR-MAS data reveals information on the nature of cytoplasmic lipid droplets (ePoster)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b34c39203e4c80ccb9fa77c6eb2c2fa"><gtr:id>9b34c39203e4c80ccb9fa77c6eb2c2fa</gtr:id><gtr:otherNames>Wilson MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>58c949ef23f6f8.70745334</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0A697FA-D30A-4673-9BB9-A9D47875D1D3</gtr:id><gtr:title>1H MAS NMR Spectroscopy of Metabolites and Lipids During Cell Growth Arrest Induced by Cisplatin in Cultured Rat Glioma BT4C Cells</gtr:title><gtr:parentPublicationTitle>Proc. Intl. Soc. Mag. Reson. Med.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73ec0788aa872a7aae6187c10577d39f"><gtr:id>73ec0788aa872a7aae6187c10577d39f</gtr:id><gtr:otherNames>Mirbahai L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>58c93eac5d7bf3.85807504</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB1C670D-3FD6-42BB-8E91-33D91AB3914D</gtr:id><gtr:title>High resolution magic angle spinning 1H NMR of childhood brain and nervous system tumours.</gtr:title><gtr:parentPublicationTitle>Molecular cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c04ecbc68b7bb5d6ee3e5d44ca60e66a"><gtr:id>c04ecbc68b7bb5d6ee3e5d44ca60e66a</gtr:id><gtr:otherNames>Wilson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1476-4598</gtr:issn><gtr:outcomeId>E35689DD074</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>461550D5-D157-47AE-B150-858758275D2F</gtr:id><gtr:title>Lipid biomarkers of glioma cell growth arrest and cell death detected by 1 H magic angle spinning MRS.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73ec0788aa872a7aae6187c10577d39f"><gtr:id>73ec0788aa872a7aae6187c10577d39f</gtr:id><gtr:otherNames>Mirbahai L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>pm_16481_21_22407940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48AB8627-01E5-4F51-8AA2-01125E96DCDF</gtr:id><gtr:title>Liquid-state, 1H NMR spectroscopy detects differences in the metabolic profiles of four high grade nervous system tumours (oral)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa6b6c24080c1135d3653d8e343c7a89"><gtr:id>fa6b6c24080c1135d3653d8e343c7a89</gtr:id><gtr:otherNames>Pan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>58c93ad695bb56.22468803</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCFFBE28-6099-4B6F-B878-B539F45367A9</gtr:id><gtr:title>&amp;sup1;H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c53e38d32cc2aec2efa3dc9f5394fc6d"><gtr:id>c53e38d32cc2aec2efa3dc9f5394fc6d</gtr:id><gtr:otherNames>Hekmatyar SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>a2ncDFi7SFo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37760F9E-8173-425F-B0E6-5E02BB15D92E</gtr:id><gtr:title>1H-Magnetic Resonance Spectroscopy as an aid to the diagnosis of brain stem tumours: a multicentre study</gtr:title><gtr:parentPublicationTitle>Neuro-Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13f5df59de5a850ae3cea047010cddca"><gtr:id>13f5df59de5a850ae3cea047010cddca</gtr:id><gtr:otherNames>Harris L.M.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>58c816944348c2.95629179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D890C1A9-67E3-48A5-A4D6-6E3FB95140FB</gtr:id><gtr:title>Compatibility between 3T 1H SV-MRS data and automatic brain tumour diagnosis support systems based on databases of 1.5T 1H SV-MRS spectra.</gtr:title><gtr:parentPublicationTitle>Magma (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1f4bea3c3c64653cd3dd807918df61d"><gtr:id>e1f4bea3c3c64653cd3dd807918df61d</gtr:id><gtr:otherNames>Fuster-Garcia E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0968-5243</gtr:issn><gtr:outcomeId>NZD8NSF4xX5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06ED1647-50C8-4F9F-A3EC-F12E266A1135</gtr:id><gtr:title>1H NMR demonstrates that oleic acid (18:1) and linoleic acid (18:2) accumulate during cell death in human Primitive Neuroectodermal Tumour cells (poster)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa6b6c24080c1135d3653d8e343c7a89"><gtr:id>fa6b6c24080c1135d3653d8e343c7a89</gtr:id><gtr:otherNames>Pan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>58c912e56278d4.43714588</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E4ED5E2-62F3-4C6D-A88B-ABD1339AFAA8</gtr:id><gtr:title>The value of magnetic resonance spectroscopy in tumour imaging.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b9e02657c63a09ff3c205dc9629081a"><gtr:id>3b9e02657c63a09ff3c205dc9629081a</gtr:id><gtr:otherNames>Peet AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>545b523e08abb1.49203319</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>010BDBBD-5169-442B-901F-2A4318EB371A</gtr:id><gtr:title>The size of cytoplasmic lipid droplets varies between tumour cell lines of the nervous system: a 1H NMR spectroscopy study.</gtr:title><gtr:parentPublicationTitle>Magma (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa6b6c24080c1135d3653d8e343c7a89"><gtr:id>fa6b6c24080c1135d3653d8e343c7a89</gtr:id><gtr:otherNames>Pan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0968-5243</gtr:issn><gtr:outcomeId>pm_16481_21_22543553</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66110BEB-5EF9-4010-8F25-51DE26B8A6CD</gtr:id><gtr:title>Magnetic resonance spectroscopy in the diagnostic evaluation of brainstem lesions in Alexander disease.</gtr:title><gtr:parentPublicationTitle>Journal of child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/613cac27f2e9fb228fd38e2caa445518"><gtr:id>613cac27f2e9fb228fd38e2caa445518</gtr:id><gtr:otherNames>Davison JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0883-0738</gtr:issn><gtr:outcomeId>aRCe4bCtgWG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F84189F2-4145-4FB4-8AD3-844B8E83AAAE</gtr:id><gtr:title>Magnetic Resonance Spectroscopy Biomarkers Predict Outcome in Paediatric Brain Tumour Patients</gtr:title><gtr:parentPublicationTitle>Neuro-oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b34c39203e4c80ccb9fa77c6eb2c2fa"><gtr:id>9b34c39203e4c80ccb9fa77c6eb2c2fa</gtr:id><gtr:otherNames>Wilson MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>58c7d3fdd3a7d0.24717797</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BD2EBC7-CB09-4F39-852C-B9E279E83AEE</gtr:id><gtr:title>Nucleotide accumulation detected by 1H NMR in rat brain glioma cells during cell death induced by cisplatin</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73ec0788aa872a7aae6187c10577d39f"><gtr:id>73ec0788aa872a7aae6187c10577d39f</gtr:id><gtr:otherNames>Mirbahai L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>58c94caebe2710.97592392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC131B58-D1B8-46DA-BACC-32E49B19CE89</gtr:id><gtr:title>Magnetic resonance spectroscopy in the assessment of pilocytic astrocytomas.</gtr:title><gtr:parentPublicationTitle>European journal of cancer (Oxford, England : 1990)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/619596e9b5957aa1ef65c12d2517f14d"><gtr:id>619596e9b5957aa1ef65c12d2517f14d</gtr:id><gtr:otherNames>Harris LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0959-8049</gtr:issn><gtr:outcomeId>F1201ACD107</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7637974-3117-461E-9BA9-4D0967488F36</gtr:id><gtr:title>Magnetic resonance spectroscopy suggests key differences in the metastatic behaviour of medulloblastoma.</gtr:title><gtr:parentPublicationTitle>European journal of cancer (Oxford, England : 1990)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b9e02657c63a09ff3c205dc9629081a"><gtr:id>3b9e02657c63a09ff3c205dc9629081a</gtr:id><gtr:otherNames>Peet AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-8049</gtr:issn><gtr:outcomeId>5EE70CA8F2D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1F36905-CB10-4ECD-943A-2425F8FE6D18</gtr:id><gtr:title>4101 ORAL Multicentre Prospective Classification of Childhood Brain Tumours Using Magnetic Resonance Spectroscopy</gtr:title><gtr:parentPublicationTitle>European Journal of Cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/740dd11515ead4510609f0bcaeac7c8c"><gtr:id>740dd11515ead4510609f0bcaeac7c8c</gtr:id><gtr:otherNames>Peet A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>58c7c9a5b27be2.78355667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CECF17A8-00B3-470E-957A-DAECEF03203E</gtr:id><gtr:title>Noninvasive detection of glutamate predicts survival in pediatric medulloblastoma.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c04ecbc68b7bb5d6ee3e5d44ca60e66a"><gtr:id>c04ecbc68b7bb5d6ee3e5d44ca60e66a</gtr:id><gtr:otherNames>Wilson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>54578db6a0e9a0.69108906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C44BB4DD-9D74-430B-AFDF-0AB09A03D399</gtr:id><gtr:title>Multicentre prospective classification of childhood brain tumours based on 1H MRS metabolite profiles</gtr:title><gtr:parentPublicationTitle>Neuro-oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5dd35d052ea8c65fd6918a9c2cf5451"><gtr:id>b5dd35d052ea8c65fd6918a9c2cf5451</gtr:id><gtr:otherNames>Davies NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>58c7daf1459313.09531349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E24473C-6240-45DC-AED5-A5BEDC6D9066</gtr:id><gtr:title>A constrained least-squares approach to the automated quantitation of in vivo &amp;sup1;H magnetic resonance spectroscopy data.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c04ecbc68b7bb5d6ee3e5d44ca60e66a"><gtr:id>c04ecbc68b7bb5d6ee3e5d44ca60e66a</gtr:id><gtr:otherNames>Wilson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>RPXRFHFexP7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D4981BA-9AF8-4DFB-A50A-9E0AAB6F5241</gtr:id><gtr:title>A comparison between simulated and experimental basis sets for the analysis of short-echo in-vivo MRS data at 1.5T (ePoster)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b34c39203e4c80ccb9fa77c6eb2c2fa"><gtr:id>9b34c39203e4c80ccb9fa77c6eb2c2fa</gtr:id><gtr:otherNames>Wilson MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>58c94a42b69f36.22424173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7C87A1C-14CD-41FA-A6BF-4BE8407E186D</gtr:id><gtr:title>A comparative study of feature extraction and blind source separation of independent component analysis (ICA) on childhood brain tumour 1H magnetic resonance spectra.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7aff0c905e83adba6771378002e25c9"><gtr:id>f7aff0c905e83adba6771378002e25c9</gtr:id><gtr:otherNames>Hao J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>2C5A1B67C35</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E434CE8F-EB64-486E-A1C5-9AD145905416</gtr:id><gtr:title>1H NMR spectroscopy analysis of isolated intracellular lipid droplets from a human cancer cell line, BE(2)M17</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa6b6c24080c1135d3653d8e343c7a89"><gtr:id>fa6b6c24080c1135d3653d8e343c7a89</gtr:id><gtr:otherNames>Pan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>58c93684d61bc0.60696818</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF68DB9A-4CA8-42E2-9D01-6170932A942A</gtr:id><gtr:title>Increased unsaturation of lipids in cytoplasmic lipid droplets in DAOY cancer cells in response to cisplatin treatment.</gtr:title><gtr:parentPublicationTitle>Metabolomics : Official journal of the Metabolomic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa6b6c24080c1135d3653d8e343c7a89"><gtr:id>fa6b6c24080c1135d3653d8e343c7a89</gtr:id><gtr:otherNames>Pan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1573-3882</gtr:issn><gtr:outcomeId>doi_55f9849841e74b19</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C40F0EB6-55C6-4ABC-B64B-C1143337A4FA</gtr:id><gtr:title>Accumulation of 1H MRS visible lipids in rat brain glioma cells during cell death induced by cisplatin (poster)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73ec0788aa872a7aae6187c10577d39f"><gtr:id>73ec0788aa872a7aae6187c10577d39f</gtr:id><gtr:otherNames>Mirbahai L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>58c953c14ec276.89375755</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>678CF511-21CA-4E81-9D28-F0921F148689</gtr:id><gtr:title>1H MRS identifies specific metabolite profiles associated with MYCN-amplified and non-amplified tumour subtypes of neuroblastoma cell lines.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b9e02657c63a09ff3c205dc9629081a"><gtr:id>3b9e02657c63a09ff3c205dc9629081a</gtr:id><gtr:otherNames>Peet AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>71E711D43EA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7EFAE14-0AAF-4A60-9045-BA930C81C311</gtr:id><gtr:title>Cytoplasmic lipid droplets - a novel indicator of tumour growth and potential theraputic target in childhood brain and nervous system tumours</gtr:title><gtr:parentPublicationTitle>Neuro-oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa6b6c24080c1135d3653d8e343c7a89"><gtr:id>fa6b6c24080c1135d3653d8e343c7a89</gtr:id><gtr:otherNames>Pan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>58c7d70e8d1076.78139674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FBB9293-B91B-4C02-9077-E61A2FA602B4</gtr:id><gtr:title>Non-invasive detection of glycine as a biomarker of malignancy in childhood brain tumours using in-vivo 1H MRS at 1.5 tesla confirmed by ex-vivo high-resolution magic-angle spinning NMR.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5dd35d052ea8c65fd6918a9c2cf5451"><gtr:id>b5dd35d052ea8c65fd6918a9c2cf5451</gtr:id><gtr:otherNames>Davies NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>05FBC2DE3ED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86C6BF5C-1D8E-48E3-8E7E-708ED5F49F94</gtr:id><gtr:title>Magnetic Resonance Spectroscopy in the assessment of Juvenile Pilocytic Astrocytomas</gtr:title><gtr:parentPublicationTitle>Neuro-Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24379fd69541a37b1698af41aec3e76c"><gtr:id>24379fd69541a37b1698af41aec3e76c</gtr:id><gtr:otherNames>Harris Lisa M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>58c8173512f6b6.22305217</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AC2B587-6CF6-483C-8922-5D63B9C1E9EF</gtr:id><gtr:title>Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion.</gtr:title><gtr:parentPublicationTitle>Neuro-oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3cf1ffc478cb19102baddd4e2c830ad"><gtr:id>e3cf1ffc478cb19102baddd4e2c830ad</gtr:id><gtr:otherNames>Hussein D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1522-8517</gtr:issn><gtr:outcomeId>YzH1xAAi8bn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D5D7B8D-BA49-4B4C-ADBD-F339FF92EEE7</gtr:id><gtr:title>The lipid composition of isolated cytoplasmic lipid droplets from a human cancer cell line, BE(2)M17.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa6b6c24080c1135d3653d8e343c7a89"><gtr:id>fa6b6c24080c1135d3653d8e343c7a89</gtr:id><gtr:otherNames>Pan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>pm_16481_21_22517214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9B01439-0288-48A9-9F41-08C91753E17C</gtr:id><gtr:title>Generating prior probabilities for classifiers of brain tumours using belief networks.</gtr:title><gtr:parentPublicationTitle>BMC medical informatics and decision making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c7bc4f2814d38789cf0c55fc1811ac9"><gtr:id>5c7bc4f2814d38789cf0c55fc1811ac9</gtr:id><gtr:otherNames>Reynolds GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1472-6947</gtr:issn><gtr:outcomeId>321E460515C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>898E45F6-810A-45D4-93FE-928A50768579</gtr:id><gtr:title>Magnetic resonance spectroscopy metabolite profiles predict survival in paediatric brain tumours.</gtr:title><gtr:parentPublicationTitle>European journal of cancer (Oxford, England : 1990)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c04ecbc68b7bb5d6ee3e5d44ca60e66a"><gtr:id>c04ecbc68b7bb5d6ee3e5d44ca60e66a</gtr:id><gtr:otherNames>Wilson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-8049</gtr:issn><gtr:outcomeId>pm_16481_21_23036848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B6C7B05-35B7-4110-8263-1C69797F94A6</gtr:id><gtr:title>The use of short-echo-time 1H MRS for childhood cerebellar tumours prior to histopathological diagnosis.</gtr:title><gtr:parentPublicationTitle>Pediatric radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/619596e9b5957aa1ef65c12d2517f14d"><gtr:id>619596e9b5957aa1ef65c12d2517f14d</gtr:id><gtr:otherNames>Harris LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0301-0449</gtr:issn><gtr:outcomeId>568259BFFF7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB0B7261-53FB-4358-AB5D-1F5446A8F67A</gtr:id><gtr:title>Changes in lipid droplet composition detected by 1H MRS during cisplatin treatment of DAOY cells (poster)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa6b6c24080c1135d3653d8e343c7a89"><gtr:id>fa6b6c24080c1135d3653d8e343c7a89</gtr:id><gtr:otherNames>Pan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>58c915215b6641.69494069</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A3A3DD9-576F-4932-86BB-BB096945616C</gtr:id><gtr:title>Multiclass imbalance learning: Improving classification of pediatric brain tumors from magnetic resonance spectroscopy.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a78c024870d1b51297bdd32d122354ba"><gtr:id>a78c024870d1b51297bdd32d122354ba</gtr:id><gtr:otherNames>Zarinabad N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>58bf214808dd74.51122096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4CAFD73-2614-45DB-9EE8-045EC4EA954E</gtr:id><gtr:title>eMagRes</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac47870d277e2a180444ede3bcf1497e"><gtr:id>ac47870d277e2a180444ede3bcf1497e</gtr:id><gtr:otherNames>Howe F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:isbn>9780470058213</gtr:isbn><gtr:outcomeId>doi_16481_emrstm1078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7CCF301-53C9-4839-BE20-63EE31F7C1F3</gtr:id><gtr:title>In vitro metabonomic study detects increases in UDP-GlcNAc and UDP-GalNAc, as early phase markers of cisplatin treatment response in brain tumor cells.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa6b6c24080c1135d3653d8e343c7a89"><gtr:id>fa6b6c24080c1135d3653d8e343c7a89</gtr:id><gtr:otherNames>Pan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>sXfmK2ppWyQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D968541-B231-49A2-8C9F-6DA560F87521</gtr:id><gtr:title>UDP-GLCNAC AND UDP-GALNAC, as detected by 1H MRS, increase in the early phase of cisplatin-induced cell death in brain tumour cells (oral</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa6b6c24080c1135d3653d8e343c7a89"><gtr:id>fa6b6c24080c1135d3653d8e343c7a89</gtr:id><gtr:otherNames>Pan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>58c916d13bafe7.45316168</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AE111DE-4624-4CE3-8AF4-608A2A9B058B</gtr:id><gtr:title>A comparison between simulated and experimental basis sets for assessing short-TE in vivo &amp;sup1;H MRS data at 1.5 T.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c04ecbc68b7bb5d6ee3e5d44ca60e66a"><gtr:id>c04ecbc68b7bb5d6ee3e5d44ca60e66a</gtr:id><gtr:otherNames>Wilson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>QrssT3RVLUw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63BB9F2B-F402-41D5-ABA0-D8829DB455C4</gtr:id><gtr:title>Characterising metabolite profiles of medulloblastomas in transgenic SMO mice using 1H magnetic resonance spectroscopy</gtr:title><gtr:parentPublicationTitle>Neuro-oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b34c39203e4c80ccb9fa77c6eb2c2fa"><gtr:id>9b34c39203e4c80ccb9fa77c6eb2c2fa</gtr:id><gtr:otherNames>Wilson MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>58c7d52a19b698.00185180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8492714C-1142-48F7-8F07-79A4FCF9CDE1</gtr:id><gtr:title>Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approaches.</gtr:title><gtr:parentPublicationTitle>Cancer biology &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f2bb6d7f87b634217a596c56a3ba0ff"><gtr:id>5f2bb6d7f87b634217a596c56a3ba0ff</gtr:id><gtr:otherNames>Kauppinen RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1538-4047</gtr:issn><gtr:outcomeId>pm_16481_21_22004946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BACDAEA-8AB9-4BC3-AEB6-FEA79079B9B3</gtr:id><gtr:title>Monitoring of gliomas in vivo by diffusion MRI and (1)H MRS during gene therapy-induced apoptosis: interrelationships between water diffusion and mobile lipids.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73dcca07b1eec113a426157c44ea016a"><gtr:id>73dcca07b1eec113a426157c44ea016a</gtr:id><gtr:otherNames>Liimatainen T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>C2D75420659</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C36F773-C33B-4DC1-A577-61D5C7E2CF69</gtr:id><gtr:title>A constrained least-squares approach to the automated quantitation of in-vivo 1H MRS data (poster)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b34c39203e4c80ccb9fa77c6eb2c2fa"><gtr:id>9b34c39203e4c80ccb9fa77c6eb2c2fa</gtr:id><gtr:otherNames>Wilson MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>58c91fc1006584.70612802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F17F3567-55C9-4C1E-8818-A1FDDAAFE93E</gtr:id><gtr:title>Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome).</gtr:title><gtr:parentPublicationTitle>Journal of inherited metabolic disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/613cac27f2e9fb228fd38e2caa445518"><gtr:id>613cac27f2e9fb228fd38e2caa445518</gtr:id><gtr:otherNames>Davison JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0141-8955</gtr:issn><gtr:outcomeId>YoX26UJvLmp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E987DDEB-0788-4479-A296-4315B75111B6</gtr:id><gtr:title>1H magnetic resonance spectroscopy metabolites as biomarkers for cell cycle arrest and cell death in rat glioma cells.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73ec0788aa872a7aae6187c10577d39f"><gtr:id>73ec0788aa872a7aae6187c10577d39f</gtr:id><gtr:otherNames>Mirbahai L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>iLvMneDcFpR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7CD40E5-E988-407A-B45D-46154BA9E6E2</gtr:id><gtr:title>A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo 1H HR-MAS for childhood brain tumours.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c04ecbc68b7bb5d6ee3e5d44ca60e66a"><gtr:id>c04ecbc68b7bb5d6ee3e5d44ca60e66a</gtr:id><gtr:otherNames>Wilson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>pm_53cd4e3d4e38e07f5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4442D5FD-9E39-4CD1-BAC7-F8F6A0ADF6C7</gtr:id><gtr:title>Linked metabolites: a tool for the construction of directed metabolic graphs.</gtr:title><gtr:parentPublicationTitle>Computers in biology and medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ab24f7ff0c61f93970ce22f1e225ffd"><gtr:id>9ab24f7ff0c61f93970ce22f1e225ffd</gtr:id><gtr:otherNames>Easton JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0010-4825</gtr:issn><gtr:outcomeId>dpXAB45wq1h</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E295B180-FCC0-4EF2-B593-3710C3D5C5D0</gtr:id><gtr:title>MRI Spectroscopy</gtr:title><gtr:parentPublicationTitle>RAD Magazine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3efc7b31668e8b55156dd19c32add565"><gtr:id>3efc7b31668e8b55156dd19c32add565</gtr:id><gtr:otherNames>Peet Andrew</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>545b9021768315.63942557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7AC899D-9CE7-47CE-9B7B-823C38FA4644</gtr:id><gtr:title>A hybrid method of application of independent component analysis to in vivo 1H MR spectra of childhood brain tumours.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7aff0c905e83adba6771378002e25c9"><gtr:id>f7aff0c905e83adba6771378002e25c9</gtr:id><gtr:otherNames>Hao J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>D1xxzyatw43</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E87C997-4464-438C-BA7A-2B285F4D5484</gtr:id><gtr:title>Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers.</gtr:title><gtr:parentPublicationTitle>Molecular cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c0469fc5dc00695f27e3bbc4f71be88"><gtr:id>9c0469fc5dc00695f27e3bbc4f71be88</gtr:id><gtr:otherNames>Wright AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1476-4598</gtr:issn><gtr:outcomeId>gwcEng4N5Hv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67074CC1-7CAE-4ACA-AFCD-430D9A63FD00</gtr:id><gtr:title>Identification and characterisation of childhood cerebellar tumours by in vivo proton MRS.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5dd35d052ea8c65fd6918a9c2cf5451"><gtr:id>b5dd35d052ea8c65fd6918a9c2cf5451</gtr:id><gtr:otherNames>Davies NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>90CA3F166E3</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601327</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>